ImmunoGen, Inc. (NASDAQ:IMGN) Q3 2023 Earnings Call Transcript November 2, 2023
ImmunoGen, Inc. beats earnings expectations. Reported EPS is $0.1, expectations were $0.02.
Operator: Good morning, ladies and gentlemen, and welcome to ImmunoGen’s Third Quarter 2023 Financial and Operating Results Conference Call. Today’s conference is being recorded. At this time, I’d like to turn the call over to Anabel Chan, Head of Investor Relations. Please go ahead.
Anabel Chan: Good morning, and thank...
